171 related articles for article (PubMed ID: 12137835)
1. Long-term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single-center study.
Steiner H; Höltl L; Wirtenberger W; Berger AP; Bartsch G; Hobisch A
Urology; 2002 Aug; 60(2):324-8. PubMed ID: 12137835
[TBL] [Abstract][Full Text] [Related]
2. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
3. Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
Reiter WJ; Brodowicz T; Alavi S; Zielinski CC; Kozak W; Maier U; Nöst G; Lipsky H; Marberger M; Kratzik C
J Clin Oncol; 2001 Jan; 19(1):101-4. PubMed ID: 11134201
[TBL] [Abstract][Full Text] [Related]
4. Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma.
Steiner H; Scheiber K; Berger AP; Rein P; Hobisch A; Aufderklamm J; Pilloni S; Stoehr B; Aigner F; Fritzer A; Zangerl F
BJU Int; 2011 Apr; 107(7):1074-9. PubMed ID: 21438975
[TBL] [Abstract][Full Text] [Related]
5. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
6. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant carboplatin treatment for seminoma clinical stage I.
Dieckmann KP; Krain J; Küster J; Brüggeboes B
J Cancer Res Clin Oncol; 1996; 122(1):63-6. PubMed ID: 8543595
[TBL] [Abstract][Full Text] [Related]
9. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR
Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin does not prevent contralateral testicular tumors in patients with seminoma.
Dieckmann KP; Matthies C; Kliesch S
J Clin Oncol; 2011 Jul; 29(21):2944-5; author reply 2945-6. PubMed ID: 21670458
[No Abstract] [Full Text] [Related]
11. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
[TBL] [Abstract][Full Text] [Related]
12. Phase II study: adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
Krege S; Kalund G; Otto T; Goepel M; Rübben H
Eur Urol; 1997; 31(4):405-7. PubMed ID: 9187898
[TBL] [Abstract][Full Text] [Related]
13. [Carboplatin monotherapy in clinical stage I of seminoma. An acceptable alternative?].
Nöst G; Lipsky H; Würnschimmel E
Urologe A; 1998 Nov; 37(6):629-34. PubMed ID: 9887492
[TBL] [Abstract][Full Text] [Related]
14. [Radiotherapy in stage I testicular seminoma: retrospective study and review of literature].
Bauduceau O; Souleau B; Le-Moulec S; Houlgatte A; Bernard O
Cancer Radiother; 2003 Dec; 7(6):386-94. PubMed ID: 14725912
[TBL] [Abstract][Full Text] [Related]
15. Sperm analysis and serum follicle-stimulating hormone levels before and after adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
Reiter WJ; Kratzik C; Brodowicz T; Haitel A; Pokorny A; Zielinski CC; Marberger M
Urology; 1998 Jul; 52(1):117-9. PubMed ID: 9671881
[TBL] [Abstract][Full Text] [Related]
16. Myths and facts on adjuvant carboplatin for stage I seminoma.
Aparicio J; Germà JR
J Clin Oncol; 2006 Jul; 24(21):e40. PubMed ID: 16849740
[No Abstract] [Full Text] [Related]
17. Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.
Diminutto A; Basso U; Maruzzo M; Morelli F; De Giorgi U; Perin A; Fraccon AP; Lo Re G; Rizzi A; Sava T; Fornarini G; Valcamonico F; Zustovich F; Massari F; Zanardi E; Roma A; Zattoni F; Zagonel V
Clin Genitourin Cancer; 2016 Apr; 14(2):e161-9. PubMed ID: 26775721
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin for stage I seminoma and the sword of Damocles.
Loehrer PJ; Bosl GJ
J Clin Oncol; 2005 Dec; 23(34):8566-9. PubMed ID: 16260692
[No Abstract] [Full Text] [Related]
19. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.
Oliver RT; Mason MD; Mead GM; von der Maase H; Rustin GJ; Joffe JK; de Wit R; Aass N; Graham JD; Coleman R; Kirk SJ; Stenning SP;
Lancet; 2005 Jul 23-29; 366(9482):293-300. PubMed ID: 16039331
[TBL] [Abstract][Full Text] [Related]
20. A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study.
Aparicio J; Sánchez-Muñoz A; Gumà J; Domenech M; Meana JA; García-Sánchez J; Bastús R; Gironés R; González-Billalabeitia E; Sagastibelza N; Ochenduszko S; Sánchez A; Terrasa J; Germà-Lluch JR; García Del Muro X;
Oncology; 2018; 95(1):8-12. PubMed ID: 29587278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
